Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2011-5-19
pubmed:abstractText
To determine the frequency of TP53 mutations and the level of p53 protein expression by immunohistochemistry (IHC) in low-risk myelodysplastic syndromes (MDS) with del(5q) and to assess their impact on disease progression.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1971-9
pubmed:dateRevised
2011-8-29
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
pubmed:affiliation
Center for Experimental Hematology M54, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. eva.hellstrom-lindberg@ki.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't